Synopsis: Tatva Chintan’s battery chemicals business has grown nearly 15 times over the past few years, driven by rising demand for electrolyte solutions. Alongside opportunities in energy storage, hybrid batteries and semiconductor chemicals, the company appears increasingly well positioned to participate in the broader electrification and energy transition themes.
The global energy transition is creating new opportunities far beyond electric vehicle manufacturers and battery producers. Rising investments in renewable energy, energy storage systems and advanced battery technologies are increasing demand for specialised materials and chemicals that form the backbone of these applications.
As countries focus on electrification and energy security, companies supplying critical battery inputs are increasingly gaining attention. This shift is also opening up new growth avenues for specialty chemical players with capabilities in electrolytes, battery materials and other high-value niche products. With a market cap of Rs 3,200 crore, the shares of Tatva Chintan Pharma Chem Ltd are trading at Rs 1,383 and are trading at a PE of 77 compared to their industry’s PE of 31.
Riding the EV Wave
Energy transition worldwide is not solely confined to electric vehicles anymore. Rising penetration of renewable energy sources, growing needs for grid balancing, and investment in battery energy storage systems are all generating entirely new drivers for the development of battery material innovations.
Electrolytes and electrolyte salts are turning out to be some of the most vital ingredients within this industry because of their significant influence on battery performance and efficiency. It is against this background that Tatva Chintan Pharma Chem is trying to carve out its place in the battery chemicals market.
Although the company has been known for its phase transfer catalysts and structure-directing agent segments so far, its electrolyte salts business is just starting to take off. Management hopes that FY27 will be the year when it starts contributing to the overall top line.
15x Battery Chemical Growth
One of the key takeaways from the recent earnings call is the tremendous growth seen in the Electrolyte Salts and Solutions (ESS) unit of the company. From just being at around Rs 11 crore a few years back, the segment revenues have grown to almost Rs 165 crore in FY26, indicating a close to fifteenfold growth in a rather short period of time. The segment accounted for roughly 3 per cent of FY26 revenues versus negligible amounts before.
Moreover, the growth seems to be speeding up even further. In just Q4 FY26, there was an unprecedented growth of 865 per cent quarter-on-quarter and 1,378 per cent year-on-year in the electrolyte salt revenues to Rs 13.1 crore. The tremendous growth suggests that the company’s past efforts to develop battery chemicals are now beginning to bear fruit.
Storage Opportunity Expands
Management emphasized that one of their customers who is active in energy storage devices has consistently increased the demand for Tatva’s electrolytes, and there will be an increase in consumption during FY27. This is especially crucial because battery energy storage systems are becoming one of the biggest opportunities around the world.
With increasing usage of renewable energy sources, the requirement of storage systems becomes more critical for balancing out the power generation. There is even scope for supercapacitors and batteries in smart grids and solar storage systems and high-power applications.
Tatva itself stated that electrolyte salts can have applications in electric vehicles, renewable energy storage, consumer electronics and even grid-balancing systems. Additionally, the company is the largest manufacturer of electrolyte salts in India for super-capacitor batteries. The market opportunity is not limited just to electric vehicles.
Bet on Hybrid Batteries
The other key point raised during the earnings call was the progress being made in the hybrid battery space. According to management, collaboration with a customer who specialises in hybrid battery technology is going well, and management expects commercial business in this segment to commence in Q3 FY27. Also, according to management, this will gradually ramp up and eventually commercialise by calendar year 2028.
It is particularly noteworthy as hybrid batteries have the benefits of regular batteries and super-capacitors, which means faster charging and more powerful performance. In case of successful commercialisation, Tatva stands to be one of those few listed Indian specialty chemical companies to have exposure to both EVs and energy storage chemistries.
Electrolytes Gain Scale
Although the electrolyte business still represents a small portion of total revenue, the management believes that in FY27 the portion of contribution made by the segment will be around 8-10 per cent of total revenues. There will be a significant increase in the contribution made in just one year.
The management is also reiterating its guidance of total revenue growth of around 25 per cent and EBITDA margin of 20-22 per cent despite geopolitical risks and the rising cost of raw materials. Given the higher value addition in electrolytes, increased contribution can help improve margins.
Growth Drivers Multiply
Surprisingly, the batteries chemical business is not the only area that drives Tatva Chintan’s growth. The company feels that it has reached the stage where a number of initiatives across the different business segments are converging. Order flow, engagement, and visibility were some of the key highlights from management in terms of these initiatives.
The SDA business is set to get a boost from the implementation of Euro 7 emission norms in Europe from 2025 onwards, with management seeing SDA revenues reaching the range of Rs 250-300 crore in FY27. The pharma business, too, seems to have reached the commercialisation phase, with management seeing the business bringing in revenues of around Rs 70-75 crore from newly commercialised products in FY27. In addition, the company has managed to get its first semiconductor chemical on pilot plant scale.
Strong Financial Recovery
Financial performance of Tatva Chintan indicates early signs of operational improvements. In FY26, the firm’s consolidated revenue was up 32 per cent year-on-year to Rs 506 crore, while its EBITDA was up 172 per cent to Rs 93 crore. The EBITDA margin rose sharply to over 18 per cent from about 9 per cent. Profit after tax (PAT) was up very significantly to Rs 42 crore from just Rs 5.7 crore in FY25.
The March quarter saw impressive performance. In Q4 FY26, its revenue was up 24 per cent year-on-year to Rs 134 crore, while EBITDA was up 214 per cent to Rs 28 crore. The PAT was up over nine times to Rs 10.3 crore.
Jolva Expansion Ahead
Tatva is also gearing up for its next capex cycle. The greenfield project of the company at Jolva is expected to commence commercial operations around 2028 and could emerge as a significant driver for growth thereafter. Management believes that Phase I of the project would have a revenue upside of around Rs 400-500 crores.
Most importantly, the new plant would also be able to improve flexibility in manufacturing and help products with high domestic demand.Additionally, management has stated that several developments coming into commercial phases could be helpful in driving growth momentum in the next two years, with Jolva helping in the next growth cycle starting FY29.
Outlook
It looks like Tatva Chintan is slowly morphing into a diversified chemicals company powered by technology with exposure to multiple sunrise industries. The company’s Electrolyte Salts segment has already achieved around 15x growth and now seems to be approaching a stage of commercial scaling, driven by growing usage in energy storage technologies and upcoming hybrid battery programmes.
In parallel, there are also emerging prospects for the company in Euro 7 chemicals, pharma chemicals, agrochemicals and semiconductor chemical segments. Even though the business from battery chemicals currently comprises a minor part of total revenues, the management believes that it will soon start making a meaningful contribution to revenues in FY27.
The shareholding pattern indicates improving investor confidence in Tatva Chintan’s long-term prospects. Ace investor Mukul Mahavir Agrawal increased his stake from 1.28 per cent in June 2025 to 2.14 per cent in September 2025 and has maintained the holding since then, reflecting continued conviction in the company’s growth story.
Foreign institutional investors have also gradually raised their stake to 3.93 per cent as of June 2026 from 3.26 per cent a year earlier. Meanwhile, domestic institutional investors have significantly reduced their holdings over the past two years, while public shareholding has steadily increased to around 21 per cent.
Provided the company continues to successfully execute its strategy and adoption of electric vehicles and energy storage solutions accelerates, Tatva Chintan may turn out to be among the very few Indian specialty chemical companies with significant participation in the energy transition theme.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
